Shortages of established products

Shortages of established products

Unlicensed medicine routes to source and import

an alternative treatment to face medicine shortages

Medicine shortages are a growing and complex global challenge. Shortages of essential drugs are becoming increasingly frequent globally, burdening health systems with additional costs and posing risks to the health of patients who fail to receive the medicines they need. More than 85% of EU hospitals report medicine shortages as an acute problem. Commonly prescribed hospital medicines undergoing shortages have significant negative impacts on patient care. A hospital facing medicine shortages without having a locally-available licensed- replacement therapy, can only find a solution by utilizing unlicensed medicine routes to source and import an alternative treatment commercially available in another country. FarmaMondo is your partner, as we serve HealthCare Providers globally with safe and uninterrupted supply of alternative to those on shortage products.

farmamondo-unlicensed-medicines-graphic2

Contact Us

Unlicensed medicine routes to source and import an alternative treatment to face medicine shortages

Medicine shortages are a growing and complex global challenge. Shortages of essential drugs are becoming increasingly frequent globally, burdening health systems with additional costs and posing risks to the health of patients who fail to receive the medicines they need. More than 85% of EU hospitals report medicine shortages as an acute problem. Commonly prescribed hospital medicines undergoing shortages have significant negative impacts on patient care. A hospital facing medicine shortages without having a locally-available licensed- replacement therapy, can only find a solution by utilizing unlicensed medicine routes to source and import an alternative treatment commercially available in another country. FarmaMondo is your partner, as we serve HealthCare Providers globally with safe and uninterrupted supply to alternative established products.

farmamondo-unlicensed-medicines-graphic2

Contact Us

 

HOW WE PROVIDE ACCESS 

Staggered launch of
new products

While market access plans of research-based pharmaceutical companies may not cover all countries equally, their patient-centric launch strategies should allow access for patients with

Shortages of established
products

Medicine shortages are a growing and complex global challenge. Shortages of essential drugs are becoming increasingly frequent globally, burdening health systems with additional costs and posing

Market exit and product
discontinuation

Market exit of a drug is a valid strategic direction for biopharmaceutical companies. Therapy discontinuation could potentially result in an unmet medical need for those patients unable to find

HOW WE PROVIDE ACCESS 

Staggered launch of
new products

While market access plans of research-based pharmaceutical companies may not cover all countries equally, their patient-centric launch strategies should allow access for patients with unmet medical needs also in non-launched countries.

Shortages of established
products

Medicine shortages are a growing and complex global challenge. Shortages of essential drugs are becoming increasingly frequent globally, burdening health systems with additional costs and posing risks to the health of patients who fail to receive the medicines they need.

Market exit and product
discontinuation

Market exit of a drug is a valid strategic direction for biopharmaceutical companies. Therapy discontinuation could potentially result in an unmet medical need for those patients unable to find suitable replacement therapies.

FOLLOW US ON